Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration
Crossref DOI link: https://doi.org/10.1007/s10147-019-01395-0
Published Online: 2019-03-02
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shigeta, Keisuke
Kosaka, Takeo https://orcid.org/0000-0002-4371-4594
Hongo, Hiroshi
Yanai, Yoshinori
Matsumoto, Kazuhiro
Morita, Shinya
Mizuno, Ryuichi
Shinojima, Toshiaki
Kikuchi, Eiji
Oya, Mototsugu
Text and Data Mining valid from 2019-03-02
Article History
First Online: 2 March 2019